Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 497 | 10q23.33 | CYP26A1 | cytochrome P450 family 26 subfamily A member 1 | |
Mouse | - | 497 | 19 C2 | Cyp26a1 | cytochrome P450, family 26, subfamily a, polypeptide 1 | |
Rat | - | - | Cyp26a1 | cytochrome P450, family 26, subfamily a, polypeptide 1 |
Database Links | |
Alphafold | O43174 (Hs), O55127 (Mm) |
BRENDA | 1.14.-.- |
ChEMBL Target | CHEMBL5141 (Hs) |
Ensembl Gene | ENSG00000095596 (Hs), ENSMUSG00000024987 (Mm), ENSRNOG00000016750 (Rn) |
Entrez Gene | 1592 (Hs), 13082 (Mm), 154985 (Rn) |
Human Protein Atlas | ENSG00000095596 (Hs) |
KEGG Enzyme | 1.14.-.- |
KEGG Gene | hsa:1592 (Hs), mmu:13082 (Mm), rno:154985 (Rn) |
OMIM | 602239 (Hs) |
Pharos | O43174 (Hs) |
UniProtKB | O43174 (Hs), O55127 (Mm) |
Wikipedia | CYP26A1 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1. Gomaa MS, Bridgens CE, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C. (2011) Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26). J Med Chem, 54 (19): 6803-11. [PMID:21838328]
2. Thatcher JE, Buttrick B, Shaffer SA, Shimshoni JA, Goodlett DR, Nelson WL, Isoherranen N. (2011) Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase. Mol Pharmacol, 80 (2): 228-39. [PMID:21521770]